resveratrol has been researched along with Becker Muscular Dystrophy in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Domi, E; Hoxha, M; Prendi, E; Zappacosta, B | 1 |
| Hayashi, T; Horio, Y; Hosoda, R; Kuno, A; Sakuragi, H; Sebori, R; Tanabe, M | 1 |
| Burt, M; Jasmin, BJ; Ljubicic, V; Lunde, JA | 1 |
| Horio, Y; Kuno, A; Tanno, M | 1 |
| Camerino, GM; Capogrosso, RF; Cozzoli, A; De Bellis, M; De Luca, A; Giustino, A; Mantuano, P; Massari, AM; Montagnani, M; Nico, B; Sblendorio, VT; Tamma, R | 1 |
| Hori, YS; Horio, Y; Hosoda, R; Kuno, A; Miura, T; Shimamoto, K; Tanno, M | 1 |
| Delgado Díaz, DC; Gordon, BS; Kostek, MC | 1 |
2 review(s) available for resveratrol and Becker Muscular Dystrophy
| Article | Year |
|---|---|
A Systematic Review on the Role of SIRT1 in Duchenne Muscular Dystrophy.
Topics: Enzyme Activators; Humans; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Resveratrol; Sirtuin 1 | 2021 |
The effects of resveratrol and SIRT1 activation on dystrophic cardiomyopathy.
Topics: Animals; Cardiomyopathies; Cardiotonic Agents; E1A-Associated p300 Protein; Enzyme Activation; Humans; Muscular Dystrophy, Duchenne; Proteolysis; Resveratrol; Sirtuin 1; Stilbenes; Ubiquitination | 2015 |
5 other study(ies) available for resveratrol and Becker Muscular Dystrophy
| Article | Year |
|---|---|
Resveratrol Ameliorates Mitophagy Disturbance and Improves Cardiac Pathophysiology of Dystrophin-deficient mdx Mice.
Topics: Animals; Antioxidants; Cardiotonic Agents; Disease Models, Animal; Dystrophin; Mice, Inbred mdx; Mitophagy; Muscular Dystrophy, Duchenne; Myocardium; Reactive Oxygen Species; Resveratrol; Treatment Outcome | 2018 |
Resveratrol induces expression of the slow, oxidative phenotype in mdx mouse muscle together with enhanced activity of the SIRT1-PGC-1α axis.
Topics: AMP-Activated Protein Kinases; Animals; Antioxidants; Disease Models, Animal; Glycolysis; Male; Mice; Mice, Inbred mdx; Muscle Development; Muscle Fibers, Slow-Twitch; Muscular Dystrophy, Duchenne; Oxidation-Reduction; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phenotype; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes; Transcription Factors | 2014 |
Assessment of resveratrol, apocynin and taurine on mechanical-metabolic uncoupling and oxidative stress in a mouse model of duchenne muscular dystrophy: A comparison with the gold standard, α-methyl prednisolone.
Topics: Acetophenones; Animals; Antioxidants; Disease Models, Animal; Male; Methylprednisolone; Mice; Mice, Inbred mdx; Muscle, Skeletal; Muscular Dystrophy, Duchenne; NADPH Oxidases; NF-kappa B; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Physical Conditioning, Animal; Reactive Oxygen Species; Resveratrol; Sirtuin 1; Stilbenes; Taurine | 2016 |
Resveratrol ameliorates muscular pathology in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy.
Topics: Animals; Antioxidants; Blotting, Western; Cell Differentiation; Cell Line; Creatine Kinase; Electroporation; Fibroblasts; Fibrosis; Histones; Immunohistochemistry; Indicators and Reagents; L-Lactate Dehydrogenase; Mice; Mice, Inbred mdx; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Oxidative Stress; Reactive Oxygen Species; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Sirtuin 1; Stilbenes | 2011 |
Resveratrol decreases inflammation and increases utrophin gene expression in the mdx mouse model of Duchenne muscular dystrophy.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Dietary Supplements; Disease Models, Animal; Inflammation Mediators; Leukocytes; Macrophages; Male; Mice; Mice, Inbred mdx; Muscle Development; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Resveratrol; RNA, Messenger; Sirtuin 1; Stilbenes; Trans-Activators; Transcription Factors; Up-Regulation; Utrophin | 2013 |